Innovationspatent Sweden

Forskarpatent specialises in the commercialisation, through licensing or new venture spinouts, of patentable inventions emanating mainly from Swedish universities. At present Forskarpatent holds a portfolio of 15 different projects in the format of shares in spinouts, partnered (licensed) and still unpartnered assets.

Business Type
Dr Mikael Lindstam
Portfolio Manager 

Karolinska Institutet Science Park Sweden

Business Type
Caroline Ekstrand
project manager 
Mrs Märit Johansson
CEO 

Lavivo AB Sweden

Lavivo helps you to a sound and healthy life, with the help of products that prevent bacterial infections and that create an ecological bacterial balance.

Lavivo was incorporated with the vision to offer products that help you achieve a balanced gastrointenstinal tract and avoid bacterial infections.

Lavivo has choosen to initially focus on synbiotic products, including beneficial bacteria (probiotics) and metabolic fibres (prebiotics), with smart delivery for optimal efficacy.

Through close cooperation with scientists and experts within the focused technologies Lavivo can offer products based on the latest developments in research.

Lavivo manufactures and markets the AptiCare® products.

Lavivo is situated in Göteborg, at the west coast of Sweden.

Website:
www.lavivo.com
Business Type
Mats Wallström
LinkedIn logo CEO 

Life Science Foresight Institute Sweden

Life Science Foresight Institute is a research institute formed to assist companies and organisations in the Life Science sector with business intelligence and futures studies.

The institute will provide client organisations with knowledge to facilitate their strategic decision-making – enabling them from the very start to hit the mark on everything from major investments in healthcare infrastructure to product development within a small enterprise.

Business Type
Mr Karl Branzen
Senior Analyst 

LipUm AB Sweden

Company: LipUm AB, Umeå, Sweden (Susanne Lindquist, Olle Hernell and Lennart Lundberg)

 LipUm AB´s goal is to develop a novel biological anti-inflammatory therapy with the protein BSSL (Bile Salt-Stimulated Lipase) as target.

 

Business Type
Professor Lennart Lundberg
VP IP and BD 

Lund Life Science Incubator Sweden

Business Type
Mr Örjan Norberg
CEO 

Medicon Village Sweden

At Medicon Village we want to create an environment where research, innovation and entrepreneurship work together to create value for people’s health and wellbeing. Together with the medical research centres Biomedical Centre (BMC) in Lund and the Clinical Research Centre (CRC) in Malmö, as well as the developing research facilities ESS and the MAX IV laboratory, Medicon Village is establishing an infrastructure of world class and thus providing a huge lift to, and enhancing the attractiveness of, the entire region. The total area available for letting within Medicon Village amounts to around 80,000 m2, of which laboratories account for about 30,000 m2. It is estimated that activities involving the employment of around 500 persons will be established within the facility during the initial phase. Later on, when the plan has been fully executed, more than 1,000 persons will be involved in the activities at Medicon Village.

Business Type
Kerstin Jakobsson
LinkedIn logo Vice President BD 

MediNasus AB Sweden

Marketing and Development of medtech products

Business Type

Mevia Sweden

Mevia develops intelligent pharmaceutical solutions to support patient adherence and increase the quality of drug treatments. With our innovative technology, each medical event is automatically registered and if a dose is forgotten the patient can immediately recieve a reminder. Our service enables closer contact between patients, healthcare and relatives. 

Website:
www.mevia.se
Business Type
Ms Linnea Olsson
LinkedIn logo Business Developmer 

Nordia Law Sweden

We are a Nordic law firm with a simple business concept : to create value for you. This is the guiding principle in everything we do. This means that we always look for solutions which not only comply with the law, but which also generate commercial advantages. It also means that it's not enough for us to obtain results. We want good results. Irrespective of the industry. Irrespective of which Nordic country is involved. Cross-border.

The business operations conducted within life science companies often involve major risks and opportunities for significant earnings. The risks come not only from the advanced scientific and supervisory environment but also from complicated business models. A key to success is for companies to be able to handle these risks. This demands that the contracts which are produced exhaustively govern all of the risks and that these risks are appropriately allocated between the parties.

NORDIA has a practice group with lawyers experienced in life science to assist national and international companies in the area, both listed companies and private companies.

Business Type
Carl Otto Lange
Lawyer, advokat 
Catharina Althini
Jur. kand., associate 
Fredrik Persson
Lawyer, advokat 
Urban Paulsson
Lawyer, advokat